Transvenous defibrillation lead systems

Journal of Cardiovascular Electrophysiology

Volumn 7, Issue 6, 1996, Pages 570-580

  Gold, Michael R ^a,b   Shorofsky, Stephen R ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

defibrillation waveforms; implantable cardioverter defibrillator; lead complications; nonthoracotomy leads

Indexed keywords

COST BENEFIT ANALYSIS; DEFIBRILLATION; DEFIBRILLATOR; HEART VENTRICLE TACHYCARDIA; HOSPITALIZATION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SURGICAL MORTALITY; TREATMENT OUTCOME;

EID: 0029936051     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1996.tb00564.x     Document Type: Review

References (82)

1. Lehmann MH, Steinman RT, Schuger CD, et al: The automatic implantable cardioverter defibrillator as antiarrhythmic treatment modality of choice for survivors of cardiac arrest unrelated to acute myocardial infarction. Am J Cardiol 1988;62:803-805.
2. Winkle RA, Mead RH, Ruder MA, et al: Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol 1989;13:1353-1361.
3. Powell AC, Fuchs T, Finkelstein DM, et al: Influence of implantable cardioverter-defibrillators on the long-term prognosis of survivors of out-of-hospital cardiac arrest. Circulation 1993;88:1083-1092.
4. Herre JM, Sauve MJ, Malone P, et al: Long-term results of amiodarone therapy in patients with recurrent sustained ventricular tachycardia or ventricular fibrillation. J Am Coll Cardiol 1989;13:442-449.
5. Poole JE, Mathisen TL, Kudenchuk PJ, et al: Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: Evaluation by electrophysiologic subgroups. J Am Coll Cardiol 1990;16:657-665.
6. Steinbeck G, Andersen D, Bach P, et al: A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias. N Engl J Med 1992;327:987-992.
7. Mason JW: A comparison of electrophysiologic testing with holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. N Engl J Med 1993;329:445-451.
8. Saksena S and The PCD Investigators: Defibrillation thresholds and perioperative mortality associated with endocardial and epicardial defibrillation lead systems. PACE 1993;16:202-207.
9. Kleman JM, Castle LW, Kidwell GA, et al: Nonthoracotomy- versus thoracotomy-implantable defibrillators. Intention-to-treat comparison of clinical outcomes. Circulation 1994;90:2833-2842.
10. Zipes DP, Roberts D: Results of the international study of the implantable pacemaker cardioverter-defibrillator. A comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65.
11. Ong JLC, Hsu PC, Lin L, et al: Arrhythmias after cardioverter-defibrillator implantation: Comparison of epicardial and transvenous systems. Am J Cardiol 1995;75:137-140.
12. Venditti FJ, O'Connell M, Martin DT, et al: Transvenous cardioverter defibrillators: Cost implications of a less invasive approach. PACE 1995;18:711-715.
13. Strickberger SA, Hummel JD, Daoud E, et al: Implantation by electrophysiologists of 100 consecutive cardioverter defibrillators with nonthoracotomy lead systems. Circulation 1994;90:868-872.
14. Fitzpatrick AP, Lesh MD, Epstein LM, et al: Electrophysiological laboratory, electrophysiologist-implanted, nonthoracotomy-implantable cardioverter/defibrillators. Circulation 1994;89:2503-2508.
15. Tung RT, Bajaj AK: Safety of implantation of a cardioverter-defibrillator without general anesthesia in an electrophysiology laboratory. Am J Cardiol 1995;75: 908-912.
16. Stanton MS, Hayes DL, Munger TM, et al: Consistent subcutaneous prepectoral implantation of a new implantable cardioverter defibrillator. Mayo Clin Proc 1994;69:309-314.
17. Brooks R, Garan H, Torchiana D, et al: Three-year outcome of nonthoracotomy approach to cardioverter-defibrillator implantation in 189 consecutive patients. Am J Cardiol 1994;74:1011-1015.
18. Kastor JA: Michel Mirowski and the automatic implantable defibrillator. Am J Cardiol 1989;63:1121-1126.
19. Mirowski M, Mower MM, Gott VL, et al: Feasibility and effectiveness of low-energy catheter defibrillation in man. Circulation 1973;47:79-85.
20. Zipes DP, Jackman WM, Heger JJ, et al: Clinical transvenous cardioversion of recurrent life-threatening tachyarrhythmias: Low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode. Am Heart J 1982;103:789-794.
21. Echt DS, Armstrong D, Schmidt P, et al: Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation 1985;71:289-296.
22. Lang DJ, Heil JE, Hahn SJ, et al: Implantable cardioverter defibrillator lead technology: Improved performance and lower defibrillation thresholds. PACE 1995;18:548-559.
23. Bardy GH, Johnson G, Poole JE, et al: A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543-547.
24. Gold MR, Foster AH, Shorofsky SR: Enhanced defibrillation efficacy with an active pectoral pulse generator. (Abstract) J Am Coll Cardiol 1995;25:407A.
25. Singer I, Adams L, Austin E: Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators. PACE 1993;16: 1070-1079.
26. Jung W, Manz M, Moosdorf R, et al: Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system. Circulation 1992;86:1217-1222.
27. Berul CI, Callans DJ, Schwartzman DS, et al: Comparison of initial detection and redetection of ventricular fibrillation in a transvenous defibrillator system with automatic gain control. J Am Coll Cardiol 1995;25: 431-436.
28. Wase A, Natale A, Dhala AA, et al: Sensing failure in a tiered therapy implantable cardioverter defibrillator: Role of auto adjustable gain. PACE 1995;18:1327-1330.
29. Hauser RG, Kurschinski DT, McVeigh K, et al: Clinical results with nonthoracotomy ICD systems. PACE 1993;16:141-148.
30. Tummala RV, Khalighi K, Weiss DN, et al: Prolonged redetection of ventricular fibrillation with an integrated lead system. (Abstract) J Am Coll Cardiol 1995;25: 4007A.
31. Blanck Z, Niazi I, Axtell K, et al: Feasibility of concomitant implantation of permanent transvenous pacemaker and defibrillator systems. Am J Cardiol 1994; 74:1249-1253.
32. Clemo HF, Ellenbogen DA, Belz MK, et al: Safety of pacemaker implantation in patients with transvenous (nonthoracotomy) implantable cardioverter defibrillators. PACE 1994;17:2285-2291.
33. Brooks R, Garan H, McGovern BA, et al: Implantation of transvenons nonthoracotomy cardioverter-defibrillator systems in patients with permanent endocardial pacemakers. Am Heart J 1995;129:45-53.
34. Hook BG, Callans DJ, Kleinman RB, et al: Implantable cardiovener-defibrillator therapy in the absence of significant symptoms: Rhythm diagnosis and management aided by stored electrogram analysis. Circulation 1993;87:1897-1906.
35. Marchlinski FE, Callans DJ, Gottlieb CD, et al: Benefits and lessons learned from stored electrogram information in implantable defibrillators. J Cardiovasc Electrophysiol 1995;6:832-851.
36. Hammell SC, Packer DL, Stanton MS, et al: Termination and acceleration of ventricular tachycardia with autodecremental pacing, burst pacing, and cardioversion in patients with an implantable cardioverter defibrillator. PACE 1995;18:3-10.
37. Trappe HJ, Fieguth HG, Pftizner P, et al: Epicardial and nonthoracotomy defibrillation lead systems combined with a cardioverter defibrillator. PACE 1995;18: 127-132.
38. Gillis AM, Leitch JW, Sheldon RS, et al: A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease. Am J Cardiol 1993;72:1146-1151.
39. Newman D, Dorian P, Hardy J: Randomized controlled comparison of antitachycardia pacing algorithms for termination of ventricular tachycardia. J Am Coll Cardiol 1993;21:1413-1418.
40. Berger MD, Waxman HL, Buxton AE, et al: Spontaneous compared with induced onset of sustained ventricular tachycardia. Circulation 1988;78:885-892.
41. Bardy GH, Poole JE, Kudenchuk PJ, et al: A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion. Circulation 1993;98:1889-1896.
42. Foster AH, Gold MR, McLaughlin JS: Effective single patch technique for cardioverter defibrillator implantation in humans. Am Heart J 1992;124:837.
43. Jordaens L, Trouerbach J-W, Vertongen P, et al: Experience of cardioverter-defibrillators inserted without thoracotomy: Evaluation of transvenously inserted intracardiac leads alone or with a subcutaneous axillary patch. Br Heart J 1993;69:14-19.
44. Brooks R, Garan H, Torchiana D, et al: Determinants of successful nonthoracotomy cardioverter-defibrillator implantation: Experience in 101 patients using two different lead systems. J Am Coll Cardiol 1993;22:1835-1842.
45. Block M, Hammel D, Bocker D, et al: A prospective randomized cross-over comparison of mono- and biphasic defibrillation using nonthoracotomy lead configurations in humans. J Cardiovasc Electrophysiol 1994;5:581-590.
46. Natale A, Sra J, Axtell K, et al: Preliminary experience with a hybrid nonthoracotomy defibrillating system that includes a biphasic device: Comparison with standard monophasic device using the same lead system. J Am Coll Cardiol 1994;24:406-412.
47. Block M, Hammel D, Isbruch F, et al: Results and realistic expectations with transvenous lead systems. PACE 1992;15:665-670.
48. Sra JS, Natale A, Axtell K, et al: Experience with two different nonthoracotomy systems for implantable defibrillator in 170 patients. PACE 1994;17:1741-1750.
49. Kopp DE, Blakeman BP, Kail JG, et al: Predictors of defibrillation energy requirements with nonepicardial lead systems. PACE 1995;18:253-260.
50. Higgins SL, Alexander DC, Kuypers CJ, et al: The subcutaneous array: A new lead adjunct for the transvenous ICD to lower defibrillation thresholds. PACE 1995;18:1540-1548.
51. Bardy GH, Hofer B, Johnson G, et al: Implantable transvenous cardioverter-defibrillators. Circulation 1993;87:1152-1168.
52. Saksena S, DeGroot P, Krol RB, et al: Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location. Circulation 1993;88:2655-2660.
53. Strickberger SA, Hummel JD, Horwood LE, et al: Effect of shock polarity on ventricular defibrillation threshold using a transvenous lead system. J Am Coll Cardiol 1994;24:1069-1072.
54. Bardy GH, Troutman C, Johnson G, et al: Electrode system influence on biphasic waveform defibrillation efficacy in humans. Circulation 1991;84:665-671.
55. Saksena S, An H, Mehra R, et al: Prospective comparison of biphasic and monophasic shocks for implantable cardioverter-defibrillators using endocardial leads. Am J Cardiol 1992;70:304-310.
56. Wyse DG, Kavanagh KM, Gillis AM, et al: Comparison of biphasic and monophasic shocks for defibrillation using a nonthoracotomy system. Am J Cardiol 1993;71:197-202.
57. Saksena S, Luceri R, Krol RB, et al: Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system. Am J Cardiol 1993;71:834-841.
58. Swartz JF, Fletcher RD, Karasik PE: Optimization of biphasic waveforms for human nonthoracotomy defibrillation. Circulation 1993;88:2646-2654.
59. Poole JE, Bardy GH, Kudenchuk PJ, et al: Prospective randomized comparison of biphasic waveform tilt using a unipolar defibrillation system. PACE 1995;18: 1369-1373.
60. Bardy GH, Poole JE, Kudenchuk PJ, et al: A prospective randomized comparison in humans of biphasic waveform 60-μF and 120-μF capacitance pulses using a unipolar defibrillation system. Circulation 1995;91: 91-95.
61. Block M, Hammel D, Bocker D, et al: Internal defibrillation with smaller capacitors: A prospective randomized cross-over comparison of defibrillation efficacy obtained with 90-μF and 125-μF capacitors in humans. J Cardiovasc Electrophysiol 1995;6:333-342.
62. Natale A, Deshpande S, Budziszewski M, et al: Defibrillation threshold with three different biphasic shapes incorporated in commercially available devices. (Abstract) Circulation 1994;90:I-499.
63. Walcott GP, Walcott KT, Knisley SB, et al: Mechanisms of defibrillation for monophasic and biphasic waveforms. PACE 1994;17:478-498.
64. Strickberger SA, Man KC, Daoud E, et al: Effect of first-phase polarity of biphasic shocks on defibrillation threshold with a single transvenous lead system. J Am Coll Cardiol 1995;25:1605-1608.
65. Natale A, Sra J, Dhala A, et al: Effects of initial polarity on defibrillation threshold with biphasic pulses. PACE 1995;18:1889-1893.
66. Raitt MH, Johnson G, Dolack GL, et al: Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. J Am Coll Cardiol 1995;25:1576-1583.
67. Wetherbee JN, Chapman PD, Troup PJ, et al: Long term internal cardiac defibrillation threshold stability. PACE 1989;12:443-450.
68. Guarnieri T, Levine J, Veltri EP, et al: Success of chronic defibrillation and the role of antiarrhythmic drugs with the automatic implantable cardioverter/defibrillator. Am J Cardiol 1987;60:1061-1064.
69. Venditti FJ, Martin DT, Vassolas G, et al: Rise in chronic defibrillation thresholds in nonthoracotomy implantable defibrillator. Circulation 1994;89:216-223.
70. Schwartzman D, Nallamothu N, Callans DF, et al: Postoperative lead-related complications in patients with nonthoracotomy defibrillation lead systems. J Am Coll Cardiol 1995;26:776-786.
71. Poole JE, Bardy GH, Dolack GL, et al: Serial defibrillation threshold measures in man: A prospective controlled study. J Cardiovasc Electrophysiol 1995;6:19-25.
72. Epstein AE, Ellenbogen KA, Kirk KA, et al: Clinical characteristics and outcomes of patients with high defibrillation thresholds: A multicenter study. Circulation 1992;86:1206-1216.
73. Almassi GH, Olinger GN, Wetherbee JN, et al: Long-term complications of implantable cardioverter defibrillator lead systems. Ann Thorac Surg 1993;55: 888-892.
74. Saksena S, Poczobutt-Johanos M, Castle LW, et al: Long-term multi-center experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. J Am Coll Cardiol 1992;19:490-499.
75. Stambler BS, Wood MA, Damiano RJ, et al: Sensing/pacing lead complications with a newer generation implantable cardioverter-defibrillator: Worldwide experience from the Guardian ATP 4210 clinical trial. J Am Coll Cardiol 1994;23:123-132.
76. Peters RW, Foster AH, Shorofsky SR, et al: Spurious discharges due to late insulation break in endocardial sensing leads for cardioverter defibrillators. PACE 1995;18:478-481.
77. Raviele A, Gasparini G, for the Italian Endotak Investigator Group: Italian Multicenter clinical experience with endocardial defibrillation: Acute and long-term results in 307 patients. PACE 1995;18:599-608.
78. Yee R, Klein GJ, Leitch JW, et al: A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator. Circulation 1992;85:196-204.
79. Roelke M, O'Nunain SS, Osswald S, et al: Subclavian crush syndrome complicating transvenous cardioverter defibrillator systems. PACE 1995;18:973-979.
80. Troup PJ, Nisam S: Complications associated with the automatic implantable cardioverter defibrillator. In Alt E, Klein H, Griffin JC, eds: The Implantable Cardioverter/Defibrillator. Springer-Verlag, Berlin, 1992, pp. 253-271.
81. Hammel D, Block M, Konertz W, et al: Surgical experience with defibrillator implantation using nonthoracotomy leads. Ann Thorac Surg 1993;55:685-693.
82. Frame R, Brodman R, Gross J, et al: Initial experience with transvenous implantable cardioverter defibrillator lead systems: Operative morbidity and mortality. PACE 1993;16:149-152.